Advertisement
HIVE vs KEEL
Which Stock Would AI Choose? HIVE Digital Technologies (HIVE) vs. Keel Infrastructure (KEEL) Stock Comparison
Key Takeaways
- Tickeron AI Verdict: Between the two, HIVE Digital Technologies (HIVE) currently presents the more consistent, verifiable setup, supported by signed contracts and recurring revenue visibility.
- Both companies are former Bitcoin miners pivoting toward AI and high-performance computing (HPC) data centers, but they are executing that shift at very different stages.
- HIVE has converted its pivot into contracted revenue, with its BUZZ HPC subsidiary reporting a GPU cloud annualized revenue run rate near $180 million.
- KEEL holds a larger power-backed development pipeline (roughly 2.2 gigawatts) but has not yet signed its major lease agreements, leaving its AI revenue largely unrealized.
- Both names carry elevated volatility and remain loss-making, so relative momentum, funding visibility, and execution risk are central to the comparison.
- For more context, explore HIVE Major News, HIVE Today's Price Move, KEEL Major News, and KEEL Today's Price Move.
- To see how AI evaluates setups like these in real time, explore Trending AI Robots.
Introduction
Investors weighing exposure to the artificial intelligence infrastructure build-out often encounter two distinct paths: companies already monetizing AI compute, and companies still converting land and power into signed contracts. HIVE Digital Technologies (HIVE) and Keel Infrastructure (KEEL) sit on opposite sides of that divide. Both began as Bitcoin miners and both are now repositioning around AI and HPC (high-performance computing) data centers, which makes their relative performance a useful case study in execution versus potential. This stock comparison is most relevant to traders and long-term investors seeking to understand how market positioning, revenue visibility, and balance-sheet strength differ between two companies pursuing the same thematic shift.
HIVE Overview and Recent Performance
HIVE Digital Technologies builds and operates green-energy data centers across Canada, Sweden, Paraguay, and Bermuda. The company runs a dual-engine strategy, pairing Bitcoin mining with a growing AI/HPC arm known as BUZZ HPC. In recent weeks, the focus has shifted decisively toward the GPU (graphics processing unit) cloud business, which has stacked up multi-year contracts, including a roughly $220 million agreement with Bell Canada and Cohere and a five-year, approximately $350 million deal to deploy Nvidia Blackwell Ultra GPUs. Management reports BUZZ HPC's annualized revenue run rate near $180 million, approaching its stated $200 million target.
Despite this commercial progress, the stock has shown meaningful relative weakness in recent market activity, trading well below its 52-week high and down sharply over the trailing year. Sentiment has been pressured by financing-related dilution concerns, widening net losses tied to accelerated depreciation, and broader weakness in the crypto-adjacent complex. Analysts nonetheless maintain a predominantly positive consensus, while some firms have trimmed price targets on near-term execution risk.
KEEL Overview and Recent Performance
KEEL Infrastructure, formerly Bitfarms, rebranded and redomiciled to the United States in 2026 as a digital infrastructure and energy company. It has fully wound down its Bitcoin mining operations and now owns a development pipeline of roughly 2.2 gigawatts (GW) across Pennsylvania, Washington State, and Québec, including the Panther Creek, Sharon, Moses Lake, and Sherbrooke sites. The company's stated model is to deliver powered shell and co-location facilities to hyperscalers and AI customers.
In recent weeks, KEEL has advanced permitting and announced partnerships, including a backup-power agreement with PowerSecure for its Moses Lake campus, and reported strong liquidity approaching $800 million. However, its AI revenue has not yet materialized, and reported revenue from continuing operations declined sharply year over year as legacy mining wound down, while operating losses remained significant. Insider buying by the CEO and a 120%-plus gain since the rebrand reflect optimism, but the shares have also experienced pronounced single-session swings on financing and valuation concerns.
Trending AI Robots
For traders seeking a more systematic approach to setups like the HIVE-versus-KEEL comparison, Tickeron's Trending AI Robots page curates the platform's best-performing automated strategies for current market conditions. Tickeron operates hundreds of AI trading bots that trade thousands of different tickers, each with its own trading style, strategy, timeframe, performance record, and universe of securities. Because not every bot suits every market environment, only those demonstrating the strongest, most relevant performance earn placement in the curated Trending AI Robots section. The page lets users compare bots by metrics such as trade counts, win rates, and drawdowns, offering a data-driven way to track relative momentum and positioning across names like these. Explore Trending AI Robots to see which strategies are currently leading.
Head-to-Head Comparison
The core contrast between these two names is realized revenue versus option value. HIVE has already signed and begun monetizing AI contracts, giving it a visible, growing revenue stream and a clearer path to cash flow, though it also carries financing costs and dilution risk. KEEL holds a larger, geographically diversified power portfolio with substantial liquidity, but its AI segment remains pre-revenue, leaving the stock more dependent on future lease execution and permitting outcomes.
On risk factors, HIVE retains meaningful exposure to Bitcoin price swings through its mining arm and has a higher beta, amplifying market moves. KEEL is less exposed to crypto after its exit but faces construction, financing, and tenant-signing risk across a capital-intensive build-out. In terms of momentum, HIVE's contracted-revenue traction has not yet translated into sustained share-price outperformance, while KEEL's stock has been more event-driven, reacting sharply to analyst actions and deal headlines.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would likely favor HIVE in the current environment. Its combination of signed multi-year GPU cloud contracts, a reported annualized revenue run rate approaching $200 million, and a more advanced commercialization stage offers greater trend consistency and a more verifiable catalyst path than KEEL's largely unrealized pipeline. While KEEL holds compelling upside optionality through its power portfolio and liquidity, that value remains contingent on future leases and permits. This assessment is probabilistic rather than definitive, reflecting relative positioning, execution visibility, and risk-adjusted momentum rather than a guarantee of future performance.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIVE is a StrongBuy and KEEL is a Buy.
HIVE's RSI Oscillator entering oversold zone
The RSI Indicator for HIVE moved into overbought territory on November 05, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +6.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in 211 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
HIVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 67 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for HIVE turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 30 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HIVE entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.008). P/E Ratio (9.174) is within average values for comparable stocks, (6.695). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (9.358) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.899).
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
KEEL in downward trend: price dove below 50-day moving average on October 05, 2026
KEEL moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 32 of 35 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KEEL as a result. In 80 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for KEEL turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 40 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
The 10-day moving average for KEEL crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The 50-day moving average for KEEL moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KEEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for KEEL entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for KEEL's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 63 cases where KEEL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
Following a +11.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where KEEL advanced for three days, in 216 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
KEEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.100) is normal, around the industry mean (2.873). P/E Ratio (-2.200) is within average values for comparable stocks, (18.687). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.239) among similar stocks. P/S Ratio (10.684) is also within normal values, averaging (139.965).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. KEEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KEEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
HIVE | KEEL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 51 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 45 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 98 | |
PRICE GROWTH RATING 1..100 | 87 | 89 | |
P/E GROWTH RATING 1..100 | 14 | 8 | |
SEASONALITY SCORE 1..100 | 90 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
KEEL's Valuation (45) in the null industry is in the same range as HIVE (68) in the Computer Communications industry. This means that KEEL’s stock grew similarly to HIVE’s over the last 12 months.
KEEL's Profit vs Risk Rating (100) in the null industry is in the same range as HIVE (100) in the Computer Communications industry. This means that KEEL’s stock grew similarly to HIVE’s over the last 12 months.
KEEL's SMR Rating (98) in the null industry is in the same range as HIVE (98) in the Computer Communications industry. This means that KEEL’s stock grew similarly to HIVE’s over the last 12 months.
HIVE's Price Growth Rating (87) in the Computer Communications industry is in the same range as KEEL (89) in the null industry. This means that HIVE’s stock grew similarly to KEEL’s over the last 12 months.
KEEL's P/E Growth Rating (8) in the null industry is in the same range as HIVE (14) in the Computer Communications industry. This means that KEEL’s stock grew similarly to HIVE’s over the last 12 months.
| HIVE | KEEL | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 78% | 2 days ago 84% |
| Momentum ODDS (%) | 5 days ago 84% | 5 days ago 87% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 89% |
| TrendWeek ODDS (%) | 2 days ago 88% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 88% | 2 days ago 90% |
| Advances ODDS (%) | 3 days ago 83% | 10 days ago 85% |
| Declines ODDS (%) | 5 days ago 90% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 81% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HIVE’s FA Score shows that 1 FA rating(s) are green while KEEL’s FA Score has 1 green FA rating(s).
- HIVE’s FA Score: 1 green, 4 red.
- KEEL’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HIVE’s TA Score shows that 4 TA indicator(s) are bullish while KEEL’s TA Score has 4 bullish TA indicator(s).
- HIVE’s TA Score: 4 bullish, 7 bearish.
- KEEL’s TA Score: 4 bullish, 7 bearish.
Price Growth
HIVE (@Investment Banks/Brokers) experienced а -21.26% price change this week, while KEEL (@Information Technology Services) price change was -28.57% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -5.48%. For the same industry, the average monthly price growth was -22.27%, and the average quarterly price growth was -27.70%.
The average weekly price growth across all stocks in the @Information Technology Services industry was -5.13%. For the same industry, the average monthly price growth was -6.17%, and the average quarterly price growth was -14.83%.
Reported Earning Dates
HIVE is expected to report earnings on Nov 13, 2026.
Industries' Descriptions
@Investment Banks/Brokers (-5.48% weekly)These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
@Information Technology Services (-5.13% weekly)The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.
Advertisement
HIVE and
Correlation & Price change
A.I.dvisor indicates that over the last year, HIVE has been closely correlated with CLSK. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if HIVE jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To HIVE | 1D Price Change % | ||
|---|---|---|---|---|
| HIVE | 100% | -10.44% | ||
| CLSK - HIVE | 76% Closely correlated | -16.47% | ||
| KEEL - HIVE | 76% Closely correlated | -21.43% | ||
| BTBT - HIVE | 75% Closely correlated | -15.38% | ||
| CIFR - HIVE | 73% Closely correlated | -14.62% | ||
| RIOT - HIVE | 73% Closely correlated | -3.97% | ||
More | ||||
KEEL and
Correlation & Price change
A.I.dvisor indicates that over the last year, KEEL has been closely correlated with CIFR. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if KEEL jumps, then CIFR could also see price increases.
| Ticker / NAME | Correlation To KEEL | 1D Price Change % | ||
|---|---|---|---|---|
| KEEL | 100% | -21.43% | ||
| CIFR - KEEL | 79% Closely correlated | -14.62% | ||
| APLD - KEEL | 76% Closely correlated | -14.69% | ||
| CLSK - KEEL | 76% Closely correlated | -16.47% | ||
| HIVE - KEEL | 76% Closely correlated | -10.44% | ||
| HUT - KEEL | 72% Closely correlated | -6.11% | ||
More | ||||